OGI
Organigram Global, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.94
+1.73%Margins
Gross margin
36.5%
EBITDA margin
6.0%
EBIT margin
-2.2%
Net margin
28.0%
FCF margin
-9.6%
15.6%
Return on equity
10.6%
Return on assets
-1.2%
Return on invested capital
0.46x
Asset turnover
-$20.2M
Cash from operations
$0.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026